2017 Progress Report: Metabolic, Microbiome and Toxicant-Related Interactions (MATRIX)EPA Grant Number: R836153C003
Subproject: this is subproject number 003 , established and managed by the Center Director under grant R836153
(EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
Center: Center for Children’s Health, the Environment, Microbiome, and Metabolomics’ Center
Center Director: McCauley, Linda
Title: Metabolic, Microbiome and Toxicant-Related Interactions (MATRIX)
Investigators: Jones, Dean P. , Corwin, Elizabeth , Li, Shuzhao
Institution: Emory University
EPA Project Officer: Louie, Nica
Project Period: September 1, 2015 through August 31, 2019
Project Period Covered by this Report: September 1, 2016 through August 31,2017
RFA: Children's Environmental Health and Disease Prevention Research Centers (2014) RFA Text | Recipients Lists
Research Category: Health , Children's Health
Aim 1: Identify maternal prenatal metabolic pathways and metabolite-microbiome correlations that link environmental exposures and preterm birth.
Aim 2: Identify maternal prenatal metabolic pathways and metabolite-microbiome correlations that link environmental exposures and infant neurodevelopment.
Aim 3: Identify infant postnatal metabolic pathways and metabolite-microbiome correlations that link environmental exposures and infant neurodevelopment.
Drs. Jones and Li have tested the planned metabolomics methodologies with legacy data, and are ready to apply those methodologies to the blood samples from Projects 1 and 2 as they are delivered to the laboratory. To this end, blood samples from the first 108 pregnant women enrolled in the P50 since January 2016 who have completed all data collections are scheduled for delivery to the Metabolomics Laboratory between May 1st and the 29th 2017.
During the next reporting period, we will carry out the activities designated in the Timeline for Year 3. Specifically, together with our trained staff and following established protocols, we will continue receiving blood samples collected from enrolled pregnant women (Project 1) and their infants (Project 2), and perform metabolomics analyses on batched samples. We will also continue data coding and entry procedures and perform data analyses, including beginning integration of environmental exposures, microbiome, and metabolomics data as related to the outcome of preterm birth. We will continue to review progress with the investigative team and make adjustments if necessary. We will continue early dissemination efforts including abstract submissions and oral or poster (student) presentations, and participation in seminars and lectures related to Project 3 and C-CHEM2. We will actively pursue manuscript submissions and publications. We will also continue to engage with the Stakeholder Advisory Board to solicit their input into how we should disseminate findings to the African American community and clinical and public health care providers for this community.
Journal Articles on this Report : 1 Displayed | Download in RIS Format
|Other subproject views:||All 10 publications||1 publications in selected types||All 1 journal articles|
|Other center views:||All 51 publications||16 publications in selected types||All 16 journal articles|
||Li S, Dunlop AL, Jones DP, Corwin EJ. High-resolution metabolomics: review of the field and implications for nursing science and the study of preterm birth. Biological Research for Nursing 2016;18(1):12-22.||
Supplemental Keywords:Metabolic, Metabolic pathway, metabolomics, environmental exposure, gut microbiome
Progress and Final Reports:Original Abstract
Main Center Abstract and Reports:R836153 Center for Children’s Health, the Environment, Microbiome, and Metabolomics’ Center
Subprojects under this Center: (EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
R836153C001 Characterizing Exposures and Outcomes in an Urban Birth Cohort (CHERUB)
R836153C002 Microbiome, Environment, and Neurodevelopmental Delay (MEND)
R836153C003 Metabolic, Microbiome and Toxicant-Related Interactions (MATRIX)